Prevalence and clinical significance of respiratory viruses and bacteria detected in tuberculosis patients compared to household contact controls in Tanzania: a cohort study.
Adult
Bacteria
/ isolation & purification
Case-Control Studies
Coinfection
/ epidemiology
Family Characteristics
Female
HIV Infections
/ complications
Humans
Male
Middle Aged
Multiplex Polymerase Chain Reaction
Nasopharynx
/ microbiology
Odds Ratio
Prevalence
Prospective Studies
Sputum
/ microbiology
Tanzania
/ epidemiology
Tuberculosis
/ epidemiology
Tuberculosis, Pulmonary
Viruses
/ isolation & purification
Young Adult
Haemophilus influenzae
Human rhinovirus virus
Influenza
Respiratory bacteria
Respiratory viruses
Tanzania
Tuberculosis
Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
31
10
2017
revised:
04
03
2018
accepted:
13
03
2018
pubmed:
28
3
2018
medline:
26
4
2019
entrez:
28
3
2018
Statut:
ppublish
Résumé
To describe the prevalence of respiratory pathogens in tuberculosis (TB) patients and in their household contact controls, and to determine the clinical significance of respiratory pathogens in TB patients. We studied 489 smear-positive adult TB patients and 305 household contact controls without TB with nasopharyngeal swab samples within an ongoing prospective cohort study in Dar es Salaam, Tanzania, between 2013 and 2015. We used multiplex real-time PCR to detect 16 respiratory viruses and seven bacterial pathogens from nasopharyngeal swabs. The median age of the study participants was 33 years; 61% (484/794) were men, and 21% (168/794) were HIV-positive. TB patients had a higher prevalence of HIV (28.6%; 140/489) than controls (9.2%; 28/305). Overall prevalence of respiratory viral pathogens was 20.4% (160/794; 95%CI 17.7-23.3%) and of bacterial pathogens 38.2% (303/794; 95%CI 34.9-41.6%). TB patients and controls did not differ in the prevalence of respiratory viruses (Odds Ratio [OR] 1.00, 95%CI 0.71-1.44), but respiratory bacteria were less frequently detected in TB patients (OR 0.70, 95%CI 0.53-0.94). TB patients with both respiratory viruses and respiratory bacteria were likely to have more severe disease (adjusted OR [aOR] 1.6, 95%CI 1.1-2.4; p 0.011). TB patients with respiratory viruses tended to have more frequent lung cavitations (aOR 1.6, 95%CI 0.93-2.7; p 0.089). Respiratory viruses are common for both TB patients and household controls. TB patients may present with more severe TB disease, particularly when they are co-infected with both bacteria and viruses.
Identifiants
pubmed: 29581053
pii: S1198-743X(18)30229-5
doi: 10.1016/j.cmi.2018.03.019
pmc: PMC7128396
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107.e1-107.e7Informations de copyright
Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Références
Tuberculosis (Edinb). 2013 May;93(3):338-42
pubmed: 23474302
Vaccine. 2011 Jul 22;29 Suppl 2:B38-41
pubmed: 21757102
PLoS One. 2016 Oct 5;11(10):e0162575
pubmed: 27706149
BMC Microbiol. 2012 Nov 23;12:276
pubmed: 23176186
Scand J Infect Dis. 2008;40(2):111-20
pubmed: 17852907
Int J Tuberc Lung Dis. 2009 Oct;13(10):1231-7
pubmed: 19793427
Infect Immun. 2011 Jan;79(1):229-37
pubmed: 20974820
J Infect Dis. 2015 Sep 1;212(5):740-4
pubmed: 25722293
PLoS Negl Trop Dis. 2017 Feb 8;11(2):e0005342
pubmed: 28178325
PLoS One. 2014 May 12;9(5):e97048
pubmed: 24819223
Pediatr Infect Dis J. 2017 Feb;36(2):179-183
pubmed: 27798551
Infect Dis Poverty. 2017 Mar 24;6(1):64
pubmed: 28335816
PLoS One. 2017 Mar 22;12(3):e0174287
pubmed: 28328944
Thorax. 2003 Jan;58(1):37-42
pubmed: 12511718
Soc Sci Med. 2009 May;68(9):1599-608
pubmed: 19304361
J Infect Dis. 2014 Jan 15;209(2):270-4
pubmed: 23935205
J Infect Dis. 2013 Dec 15;208 Suppl 3:S207-16
pubmed: 24265480
J Immunol. 2013 Jul 1;191(1):302-11
pubmed: 23698750
PLoS One. 2013 Dec 13;8(12):e83445
pubmed: 24349510
Am J Trop Med Hyg. 2017 Jun;96(6):1274-1284
pubmed: 28719264
J Clin Virol. 2013 Aug;57(4):338-42
pubmed: 23743345
Lancet Infect Dis. 2013 May;13(5):436-48
pubmed: 23531392
J Am Med Inform Assoc. 2016 Sep;23(5):916-23
pubmed: 26911813